tradingkey.logo
搜索

Rapid Micro Biosystems Inc

RPID
添加自选
1.700USD
-0.010-0.58%
收盘 07/02, 13:00美东报价延迟15分钟
75.78M总市值
亏损市盈率 TTM

Rapid Micro Biosystems Inc

1.700
-0.010-0.58%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.58%

5天

+1.19%

1月

-13.71%

6月

-41.38%

今年开始到现在

-41.38%

1年

-51.29%

关键数据
1.730今开
1.730最高
76.01K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.17%换手率
1.710昨收
1.700最低
90.47K成交额
亏损市盈率静
2.28市净率
0.00%股息率 TTM
-67.84%ROA
4.94052周最高
0.64量比
-46.89M净利润
44.58M总股本
-1.1129每股收益TTM
1.47Beta
-116.74%ROE
1.86052周最低
1.75%振幅
4.64%毛利率
75.78M总市值
-2.50回报/风险
5.10%风险率

TradingKey Rapid Micro Biosystems Inc股票评分

单位: USD 更新时间: 2026-07-01

操作建议

Rapid Micro Biosystems Inc当前公司基本面数据相对稳定,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名113/204位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价6.67。中期看,股价处于下降通道。近一个月,市场表现较差,但技术面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Rapid Micro Biosystems Inc评分

相关信息

行业排名
113 / 204
全市场排名
295 / 4564
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Rapid Micro Biosystems Inc亮点

亮点风险
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
业绩高增长
公司营业收入稳步增长,连续3年增长49.15%
业绩增长期
公司处于发展阶段,最新年度总收入33.59M美元
估值合理
公司最新PE估值-1.54,处于3年历史合理位
机构加仓
最新机构持股25.08M股,环比增加2.37%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值0.00

分析师目标

根据 4 位分析师
买入
评级
6.667
目标均价
+285.36%
涨幅空间

Rapid Micro Biosystems Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Rapid Micro Biosystems Inc简介

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
公司代码RPID
公司Rapid Micro Biosystems Inc
CEOSpignesi (Robert)
网址https://www.rapidmicrobio.com/

常见问题

Rapid Micro Biosystems Inc(RPID)的当前股价是多少?

Rapid Micro Biosystems Inc(RPID)的当前股价是 1.71。

Rapid Micro Biosystems Inc的股票代码是什么?

Rapid Micro Biosystems Inc的股票代码是RPID。

Rapid Micro Biosystems Inc股票的52周最高点是多少?

Rapid Micro Biosystems Inc股票的52周最高点是4.94。

Rapid Micro Biosystems Inc股票的52周最低点是多少?

Rapid Micro Biosystems Inc股票的52周最低点是1.86。

Rapid Micro Biosystems Inc的市值是多少?

Rapid Micro Biosystems Inc的市值是84.51M。

现在Rapid Micro Biosystems Inc(RPID)的股票是买入、持有还是卖出?

根据分析师评级,Rapid Micro Biosystems Inc(RPID)的总体评级为买入,目标价格为6.67。

Rapid Micro Biosystems Inc(RPID)股票的每股收益(EPS TTM)是多少

Rapid Micro Biosystems Inc(RPID)股票的每股收益(EPS TTM)是-1.05。